Francisco B. de Lacy

Hospital Clínic de Barcelona

Papers

1

Total Citations

17

H-Index

1

About

Francisco B. de Lacy is a pioneering colorectal surgeon whose work has fundamentally shaped modern approaches to rectal cancer treatment, particularly through the development and refinement of transanal total mesorectal excision (TaTME). His key research areas include minimally invasive surgical techniques, oncologic outcomes in rectal cancer, and evidence-based guideline development. De Lacy’s major contribution lies in advancing TaTME as a safer, more precise alternative to traditional open surgery, helping reduce recurrence rates and improve patient recovery. He co-led the landmark UEG and EAES rapid guideline (2022, 17 citations), which provided the first systematic review, meta-analysis, and GRADE-based European recommendations on TaTME—a critical step in standardizing practice amid conflicting evidence. This work exemplifies his commitment to bridging surgical innovation with rigorous methodology. With a career spanning decades at the Hospital Clínic of Barcelona, de Lacy has trained countless surgeons worldwide and published extensively on laparoscopic and transanal techniques. His impact is reflected not only in citation counts but in the widespread adoption of TaTME, which has transformed rectal cancer surgery globally.

Research Focus

Key Achievements

1
H-Index
1
Papers
17
Total Citations
17
Avg Citations/Paper
🏆 Most Cited Paper
UEG and EAES rapid guideline: Systematic review, meta-analysis, GRADE assessment and evidence-informed European recommendations on TaTME for rectal cancer
17 citations · 2022
📈 Most Prolific Year: 2022 (1 Papers)
🤝 Key Collaborators: 16
🏛 Institutions: Hospital Clínic de Barcelona

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago